Search

Catherine R. Oliver-garcia

Examiner (ID: 9259, Phone: (571)272-2655 , Office: P/2914 )

Most Active Art Unit
2914
Art Unit(s)
2904, 2900, 2914
Total Applications
7479
Issued Applications
7429
Pending Applications
0
Abandoned Applications
54

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6260015 [patent_doc_number] => 20020187507 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-12 [patent_title] => 'Polynucleotides related to pancreatic disease' [patent_app_type] => new [patent_app_number] => 10/165835 [patent_app_country] => US [patent_app_date] => 2002-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22398 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0187/20020187507.pdf [firstpage_image] =>[orig_patent_app_number] => 10165835 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/165835
Polynucleotides related to pancreatic disease Jun 5, 2002 Abandoned
Array ( [id] => 6791922 [patent_doc_number] => 20030087266 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-05-08 [patent_title] => 'IGs as modifiers of the p53 pathway and methods of use' [patent_app_type] => new [patent_app_number] => 10/161572 [patent_app_country] => US [patent_app_date] => 2002-06-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16595 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0087/20030087266.pdf [firstpage_image] =>[orig_patent_app_number] => 10161572 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/161572
IGs as modifiers of the p53 pathway and methods of use Jun 2, 2002 Abandoned
Array ( [id] => 6692569 [patent_doc_number] => 20030040001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-27 [patent_title] => 'LETM1: modulators of cellular proliferation' [patent_app_type] => new [patent_app_number] => 10/160663 [patent_app_country] => US [patent_app_date] => 2002-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14555 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20030040001.pdf [firstpage_image] =>[orig_patent_app_number] => 10160663 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/160663
LETM1: modulators of cellular proliferation May 30, 2002 Issued
Array ( [id] => 1073885 [patent_doc_number] => 06838550 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-04 [patent_title] => 'Suppressors of death domains' [patent_app_type] => utility [patent_app_number] => 10/161346 [patent_app_country] => US [patent_app_date] => 2002-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3995 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/838/06838550.pdf [firstpage_image] =>[orig_patent_app_number] => 10161346 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/161346
Suppressors of death domains May 29, 2002 Issued
Array ( [id] => 556656 [patent_doc_number] => 07160993 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-09 [patent_title] => 'Nucleic acids encoding PRO4400 polypeptides' [patent_app_type] => utility [patent_app_number] => 10/152375 [patent_app_country] => US [patent_app_date] => 2002-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 550 [patent_figures_cnt] => 550 [patent_no_of_words] => 58852 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/160/07160993.pdf [firstpage_image] =>[orig_patent_app_number] => 10152375 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/152375
Nucleic acids encoding PRO4400 polypeptides May 20, 2002 Issued
Array ( [id] => 1080223 [patent_doc_number] => 06835381 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-12-28 [patent_title] => 'Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor' [patent_app_type] => B1 [patent_app_number] => 10/018386 [patent_app_country] => US [patent_app_date] => 2002-05-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 26308 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/835/06835381.pdf [firstpage_image] =>[orig_patent_app_number] => 10018386 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/018386
Methods for modulating angiogenesis by using the anti-angiogenic angiotensin-7 and polynucleotides encoding therefor May 16, 2002 Issued
10/129848 Depletion of cellular coenzyme-a levels as a means to selectively kill cancer cells May 9, 2002 Abandoned
Array ( [id] => 6829779 [patent_doc_number] => 20030180837 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-25 [patent_title] => 'Secreted and transmembrane polypeptides and nucleic acids encoding the same' [patent_app_type] => new [patent_app_number] => 10/063510 [patent_app_country] => US [patent_app_date] => 2002-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 169 [patent_figures_cnt] => 169 [patent_no_of_words] => 45528 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 112 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20030180837.pdf [firstpage_image] =>[orig_patent_app_number] => 10063510 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/063510
Secreted and transmembrane polypeptides and nucleic acids encoding the same Apr 30, 2002 Issued
Array ( [id] => 122083 [patent_doc_number] => 07704496 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-27 [patent_title] => 'Antibodies against PRO1341 polypeptide' [patent_app_type] => utility [patent_app_number] => 10/128692 [patent_app_country] => US [patent_app_date] => 2002-04-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 550 [patent_figures_cnt] => 550 [patent_no_of_words] => 58833 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/704/07704496.pdf [firstpage_image] =>[orig_patent_app_number] => 10128692 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/128692
Antibodies against PRO1341 polypeptide Apr 22, 2002 Issued
Array ( [id] => 556020 [patent_doc_number] => 07157248 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-01-02 [patent_title] => 'CDNA encoding the human α2 δ4 calcium channel subunit' [patent_app_type] => utility [patent_app_number] => 10/119624 [patent_app_country] => US [patent_app_date] => 2002-04-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 25086 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 48 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/157/07157248.pdf [firstpage_image] =>[orig_patent_app_number] => 10119624 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/119624
CDNA encoding the human α2 δ4 calcium channel subunit Apr 9, 2002 Issued
Array ( [id] => 982047 [patent_doc_number] => 06926890 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-08-09 [patent_title] => 'Non-invasive approach for assessing tumors in living animals' [patent_app_type] => utility [patent_app_number] => 10/114030 [patent_app_country] => US [patent_app_date] => 2002-04-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 6584 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/926/06926890.pdf [firstpage_image] =>[orig_patent_app_number] => 10114030 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/114030
Non-invasive approach for assessing tumors in living animals Apr 2, 2002 Issued
10/019348 Prostate-specific polynucleotides, polypeptides and their methods of use Apr 1, 2002 Abandoned
Array ( [id] => 6797460 [patent_doc_number] => 20030176334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Methods and compositions useful for inhibition of angiogenesis' [patent_app_type] => new [patent_app_number] => 10/115223 [patent_app_country] => US [patent_app_date] => 2002-04-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 46 [patent_no_of_words] => 40382 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176334.pdf [firstpage_image] =>[orig_patent_app_number] => 10115223 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/115223
Methods and compositions useful for inhibition of angiogenesis Apr 1, 2002 Abandoned
Array ( [id] => 6527394 [patent_doc_number] => 20020192729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Apo-2LI and Apo-3 polypeptides' [patent_app_type] => new [patent_app_number] => 10/112793 [patent_app_country] => US [patent_app_date] => 2002-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24174 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20020192729.pdf [firstpage_image] =>[orig_patent_app_number] => 10112793 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/112793
Apo-2LI and Apo-3 polypeptides Mar 27, 2002 Abandoned
Array ( [id] => 6710497 [patent_doc_number] => 20030170246 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-11 [patent_title] => 'Lipophilin complexes for use in cancer diagnosis and therapy' [patent_app_type] => new [patent_app_number] => 10/096319 [patent_app_country] => US [patent_app_date] => 2002-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 26565 [patent_no_of_claims] => 57 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20030170246.pdf [firstpage_image] =>[orig_patent_app_number] => 10096319 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/096319
Lipophilin complexes for use in cancer diagnosis and therapy Mar 11, 2002 Abandoned
Array ( [id] => 6778570 [patent_doc_number] => 20030049651 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-13 [patent_title] => 'Tumor associated proteins' [patent_app_type] => new [patent_app_number] => 10/092012 [patent_app_country] => US [patent_app_date] => 2002-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 17324 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0049/20030049651.pdf [firstpage_image] =>[orig_patent_app_number] => 10092012 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/092012
Tumor associated proteins Mar 4, 2002 Abandoned
Array ( [id] => 6306076 [patent_doc_number] => 20020094542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-18 [patent_title] => 'Drugs and methods for treating cancer' [patent_app_type] => new [patent_app_number] => 10/087252 [patent_app_country] => US [patent_app_date] => 2002-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 18587 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20020094542.pdf [firstpage_image] =>[orig_patent_app_number] => 10087252 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/087252
Drugs and methods for treating cancer Feb 28, 2002 Abandoned
Array ( [id] => 6156643 [patent_doc_number] => 20020146389 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'DNA19355 polypeptide, a tumor necrosis factor homolog' [patent_app_type] => new [patent_app_number] => 10/080455 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20064 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20020146389.pdf [firstpage_image] =>[orig_patent_app_number] => 10080455 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/080455
DNA19355 polypeptide, a tumor necrosis factor homolog Feb 21, 2002 Abandoned
Array ( [id] => 1101382 [patent_doc_number] => 06815166 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-11-09 [patent_title] => 'HIN-1, a tumor suppressor gene' [patent_app_type] => B2 [patent_app_number] => 10/081817 [patent_app_country] => US [patent_app_date] => 2002-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 54 [patent_no_of_words] => 19368 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 144 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/815/06815166.pdf [firstpage_image] =>[orig_patent_app_number] => 10081817 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/081817
HIN-1, a tumor suppressor gene Feb 21, 2002 Issued
Array ( [id] => 6274742 [patent_doc_number] => 20020106376 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Therapeutic or prophylactic composition of fibronectin-binding protein 1 (SFBI) as adjuvant' [patent_app_type] => new [patent_app_number] => 10/059670 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6210 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106376.pdf [firstpage_image] =>[orig_patent_app_number] => 10059670 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/059670
Therapeutic or prophylactic composition of fibronectin-binding protein 1 (SFBI) as adjuvant Jan 29, 2002 Abandoned
Menu